Melphalan 140 mg/m(2) or 200 mg/m(2) for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party

Thumbnail
Fulltext:
190028.pdf
Size:
1.751Mb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2018
Author(s)
Auner, Holger W.
Iacobelli, S.
Sbianchi, Giulia
Knol-Bout, Cora
Blaise, D.
Russell, Nigel H.
Schaap, N.P.M.
Garderet, L.
Kroeger, Nicolaus
Source
Haematologica, 103, 3, (2018), pp. 514-521
ISSN
DOI
Publication type
Article / Letter to editor
If a DOI or any other persistent identifier is unavailable, please use the following repository identifier to link to this item: https://hdl.handle.net/2066/190028   https://hdl.handle.net/2066/190028
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.